OTCMKTS:NDVAF Indiva (NDVAF) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 05/22/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Indiva Stock (OTCMKTS:NDVAF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Indiva alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.02▼$0.0252-Week Range$0.01▼$0.09VolumeN/AAverage Volume42,509 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Indiva Ltd. is a Canadian licensed producer of cannabis edibles, concentrates and infused products. The company specializes in the development, manufacturing and distribution of a diverse portfolio of THC- and CBD-infused offerings, including chocolates, gummies, baked goods, and oil-based convenience formats. By focusing on value-added derivatives, Indiva aims to address evolving consumer preferences in the recreational and adult-use cannabis markets. Founded in 2016 and headquartered in Saskatoon, Saskatchewan, Indiva operates a Health Canada–approved production facility where it oversees product formulation, quality control and packaging under one roof. The company’s vertically integrated approach allows for end-to-end management of the manufacturing process, from ingredient sourcing through third-party testing protocols. Indiva leverages proprietary formulations and strategic partnerships with ingredient suppliers to enhance product consistency, compliance and shelf stability. Indiva’s products are distributed nationally through provincial liquor and cannabis boards, as well as select private retailers. With a focus on innovation and consumer experience, the company continues to expand its lineup of functional and pectin-based edibles while pursuing opportunities in emerging product categories across Canada’s regulated adult-use market.AI Generated. May Contain Errors. Read More Receive NDVAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NDVAF Stock News HeadlinesWhy BeachFleischman acquired cannabis accounting firm Indiva AdvisorsDecember 11, 2024 | bizjournals.comBeachFleischman expands Cannabis Practice with addition of Las Vegas-based Indiva AdvisorsDecember 3, 2024 | uk.finance.yahoo.comSpaceX billions need somewhere to go — this is itThe SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed out aren't parking that money in a savings account. They're rotating it into the next big multiplier. Fast. We believe we've found exactly where it's going. Its partners include BlackRock, Circle, and Stripe. Major financial terminals already use it behind the scenes. Right now… before the SpaceX IPO even happens… it's already engineering a supply shock.The IPO is coming. The rotation will be fast.May 28 at 1:00 AM | Crypto 101 Media (Ad)Indiva (OTC:NDVAF) Stock Quotes, Forecast and News SummaryJuly 24, 2024 | benzinga.comIndiva Reports First Quarter 2024 ResultsMay 23, 2024 | businesswire.comIndiva Announces Closing of the First Tranche of Life Offering & Provides Update on Previously Announced Private PlacementMarch 4, 2024 | finance.yahoo.comIndiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 MillionFebruary 28, 2024 | finance.yahoo.comIndiva’s Strong Sales and Market Share Gains Prompt Buy Rating and Raised Price TargetJanuary 6, 2024 | markets.businessinsider.comSee More Headlines NDVAF Stock Analysis - Frequently Asked Questions How have NDVAF shares performed this year? Indiva's stock was trading at $0.0210 at the start of the year. Since then, NDVAF stock has increased by 0.0% and is now trading at $0.0210. How do I buy shares of Indiva? Shares of NDVAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:NDVAF CIKN/A Webwww.indiva.com Phone(888) 649-6686FaxN/AEmployees95Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:NDVAF) was last updated on 5/28/2026 by MarketBeat.com Staff. From Our PartnersWall Street’s $3.3B critical mineral darling just got spanked by a $300M junior …NevGold Corp. (OTCQX: NAUFF) just released drill results showing up to 53.71% antimony - potentially one of th...i2i Marketing Group, LLC | SponsoredSpaceX billions need somewhere to go — this is itThe SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...Crypto 101 Media | SponsoredBNZI Breakout Watch: AI Growth Meets Turnaround Setup!Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...Huge Alerts | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe math on the SpaceX IPO is brokenSpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...Weiss Ratings | SponsoredThey're not telling you how bad this could getValuations are stretched to levels seen only a handful of times in the last hundred years — yet most retiremen...Parkview Capital Group | SponsoredWhen SpaceX goes public your retirement pays the priceWhen SpaceX files its S-1, institutions will liquidate holdings, rebalance portfolios, and free up capital for...Reagan Gold Group | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indiva Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Indiva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.